Navigating the drug regulatory approval process is costly and demands broad technical and commercial skills, which are concentrated in the private sector.
The National Surveillance on Antibiotic Resistance has indicated that we have almost every variety of antibiotic resistance thus far documented including some which have not yet made an appearance in other parts of the world.